MSB 3.21% $1.13 mesoblast limited

Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-60

  1. 8,948 Posts.
    lightbulb Created with Sketch. 6809
    I'm surprised its only up 22% and was able to buy more this morning , should be up 200% , this real world class leading news, MSB,, has been unleashed to the , 83% survival rate compared to 9% is amazing , so far nothing else works but for MSB on Co-19 , well done investors .
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.